159 Developing placental CD34+-derived natural killer cells with high affinity cleavage resistant CD16 (CYNK-101) and Cetuximab for enhanced therapy of EGFR+ non-small cell lung an... by Lin Kang, Xiaokui Zhang, Robert Hariri, Xuan Guo, Tanel Mahlakõiv, Shuyang He, Hemlata Rana, Andrea DiFiglia, John Fitzgerald, Irene Raitman, Valentina Rousseva, Salvatore Rotondo